Neuralstem, Inc. (NASDAQ:CUR)’s share price reached a new 52-week low on Tuesday . The company traded as low as $0.57 and last traded at $0.60, with a volume of 200 shares traded. The stock had previously closed at $0.63.
Neuralstem (NASDAQ:CUR) last announced its quarterly earnings results on Wednesday, August 15th. The company reported ($0.04) EPS for the quarter. Neuralstem had a negative net margin of 1,401.80% and a negative return on equity of 75.90%. The firm had revenue of $0.25 million for the quarter.
Neuralstem Company Profile (NASDAQ:CUR)
Neuralstem, Inc, a clinical stage biopharmaceutical company, focuses on the research and development of nervous system therapies based on its proprietary human neuronal stem cells and small molecule compounds. The company's stem cell based technology enables the isolation and expansion of human neural stem cells from various areas of the developing human brain and spinal cord enabling the generation of physiologically relevant human neurons of various types.
Receive News & Ratings for Neuralstem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neuralstem and related companies with MarketBeat.com's FREE daily email newsletter.